Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.41 |
| ▸ | TOP1 | P11387 | 2/20 | 0.39 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | CCR8 | P51685 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20733851 | 0.95 | L3MBTL1 (0.41) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL12761842 | 0.89 | NPC1 (0.45) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL20733736 | 0.86 | ALDH1A1 (0.37) | GP6TOP1CCR1CCR8L3MBTL1 | |
| SCHEMBL20733872 | 0.84 | ALDH1A1 (0.35) | CCR1CCR8L3MBTL1ALDH1A1DHFR | |
| SCHEMBL20733802 | 0.83 | L3MBTL1 (0.39) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL20733786 | 0.83 | CYP1A2 (0.47) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL20733796 | 0.82 | L3MBTL1 (0.48) | CCR1CCR8L3MBTL1ALDH1A1DHFR | |
| SCHEMBL20733790 | 0.79 | ALDH1A1 (0.41) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL20733789 | 0.79 | ALDH1A1 (0.41) | TOP1CCR1CCR8L3MBTL1ALDH1A1 | |
| SCHEMBL20733799 | 0.78 | ALDH1A1 (0.40) | GP6L3MBTL1ALDH1A1DHFRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230057590-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2023-02-23 | — | — | US | disclosed |
| US-20190051842-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230057590-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OXER1 | GP6 4204/4885TOP1 1908/4885CCR1 3521/4885 |
| US-20190051842-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OXER1 | GP6 4204/4885TOP1 1908/4885CCR1 3521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.